Abstract
BackgroundThe PedsQL™3.0 Diabetes Module is a widely used instrument to measure the disease-specific health-related quality of life summary measures in children and adolescents with type 1 diabetes. After cultural adaptation, we confirmed reliability and validity of PedsQL™3.0 Diabetes Module in its Italian version.MethodsParticipants were 169 Italian children and adolescents with type 1 diabetes aged 5–18 years and 100 parents. Reliability was determined by internal consistency using Cronbach’s coefficient alpha, and test-retest reliability by intra-class correlation coefficient (ICC). Validity was assessed through factor validity examined by exploratory factor analysis, and discriminant validity examined through multitrait/multi-item scaling analysis. Discriminant validity with respect to dichotomous patients’ characteristics at baseline was also examined through a multivariate analysis on the summary measures using the Wilks’ Lambda test.ResultsData completeness was optimal. Item internal consistency was satisfied at 89% for the child self-report scales and at 100% for the parents’ proxy-report scales. Most diabetes module scales was acceptable for group comparisons. Discriminant validity was satisfied for 71% of children and adolescents and for 82% of parents. A ≥70% Cronbach’s α coefficient was found for the summary measures of both reports. For the test-retest reliability, the ICC coefficients ranged from 0.66 (i.e., the Worry scale) to 0.82 for the other scales of the child self-report. The ICC coefficients were ≥0.87 for all the parents’ proxy-report scales. Factor analysis showed that the PedsQL™3.0 Diabetes Module for child self-report could be summarized in 10 components, which explained the 62% of the variance. For the parent proxy-report the statistical analysis selected 9 factors, which explained about 68% of variance. The external discriminant validity of the PedsQL™3.0 Diabetes Module summary measures were compared across gender, age, time since diagnosis and HbA1c mean cut off values. Significant differences in the “Treatment adherence” scale and in the “Communication” scale were observed across age, and by time since diagnosis.ConclusionsThe results show the reliability and validity of the Italian translation of the PedsQL™3.0 Diabetes Module, supporting therefore its use as an outcome measure for diabetes cross-national clinical trials and research.
Highlights
The PedsQLTM3.0 Diabetes Module is a widely used instrument to measure the disease-specific health-related quality of life summary measures in children and adolescents with type 1 diabetes
The PedsQLTM3.0 Diabetes Module questionnaire has been assessed to measure diabetes-specific quality of life (QOL) dimensions in both children and their parents: either PedsQLTM4.0 or PedsQLTM3.0 Diabetes Module have been tailored for a broad age range including child self-report for ages 5–18 years, and parents’ proxy-report for their children for ages 2–18 years [10]
Factor analysis showed that the PedsQLTM3.0 Diabetes Module for child self-report could be summarized into 10 components, which explain the 62% of the variance
Summary
The PedsQLTM3.0 Diabetes Module is a widely used instrument to measure the disease-specific health-related quality of life summary measures in children and adolescents with type 1 diabetes. A health-related quality of life (HRQOL) measurement should include physical, mental and social health aspects, be based on different age patient’s perception, and provide evidence of acceptance and reliability. The PedsQLTM4.0 Generic Score Scales distinguish between healthy children and those affected by acute or chronic diseases and provide evidence of good feasibility, reliability and sensitivity to different diseases in several reports [7,8,9]. The PedsQLTM3.0 Diabetes Module questionnaire has been assessed to measure diabetes-specific QOL dimensions in both children and their parents: either PedsQLTM4.0 or PedsQLTM3.0 Diabetes Module have been tailored for a broad age range including child self-report for ages 5–18 years, and parents’ proxy-report for their children for ages 2–18 years [10]. Feasibility, reliability and validity of the new electronic version of e-PedsQLTM for type 1 and type 2 diabetes has been successfully demonstrated [11]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.